D-1001-2019 Class II Terminated
FDA drug recall D-1001-2019 was initiated by Dr. Reddy's Laboratories, Inc. on Mar 6, 2019 and is designated Class II. Reason for recall: Defective Container: complaint for seal and cap vial issues that could lead to a lack of sterility assurance. The recall status is terminated (terminated May 16, 2022). Affected quantity: 5,755 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 20, 2019
- Initiation Date
- Mar 6, 2019
- Termination Date
- May 16, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5,755 vials
Product description
Docetaxel Injection USP, 80 mg/4 mL, (20 mg/mL), One-Vial Formulation, Rx only, Mfd By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, Andhra Pradesh, INDIA, NDC 43598-259-40.
Reason for recall
Defective Container: complaint for seal and cap vial issues that could lead to a lack of sterility assurance.
Distribution pattern
Nationwide in the USA
Code information
Lot#: H7081, Exp 07/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1001-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026